Abillion
A social media platform focused on sustainability and plant-based living
Abillion is a social media platform and online community dedicated to promoting sustainability, plant-based living, and ethical consumerism. Founded in 2017 by Vikas Garg, Abillion aims to connect individuals who are passionate about making a positive impact on the planet through their lifestyle choices. The platform encourages users to share reviews and recommendations of vegan and sustainable products, thereby fostering a community of conscious consumers.
History[edit | edit source]
Abillion was established in 2017 with the mission to drive positive change in the world by influencing consumer behavior towards more sustainable and ethical choices. The platform was created to address the growing demand for plant-based and eco-friendly products, providing a space where users can discover and review such items.
Features[edit | edit source]
Abillion offers a variety of features designed to engage its community and promote sustainable living:
Product Reviews[edit | edit source]
Users can write reviews of plant-based and sustainable products, ranging from food items to personal care products. These reviews help other users make informed purchasing decisions and support brands that align with their values.
Social Networking[edit | edit source]
The platform functions as a social network where users can follow each other, share posts, and engage in discussions about sustainability and ethical living. This community aspect is central to Abillion's mission of fostering a global movement towards a more sustainable future.
Impact Program[edit | edit source]
Abillion has an impact program that allows users to contribute to various causes. For every review written, users earn credits that can be donated to partner organizations focused on animal welfare, environmental conservation, and social justice.
Community and Influence[edit | edit source]
Abillion has grown into a global community with users from over 140 countries. The platform has become a valuable resource for individuals seeking to live more sustainably and for brands looking to reach a conscious audience. By leveraging the power of community and social media, Abillion aims to accelerate the transition to a more sustainable world.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
